Krisztian Magori reports on the exciting new results of a phase II clinical trial of the R21 malaria vaccine, which shows safety and high levels of… Read more »
Recent research leads to a new hypothesis explaining the interaction between malaria parasites and receptors on the cells lining the brain… Read more »
Evidence of shared immunodominance between Plasmodium falciparum and SARS-CoV-2 may explain low COVID-19 incidence in the… Read more »
This is the first time that An. coustani is found to be a major local malaria vector in Madagascar.
A Kenyan based group of researchers have identified a new microsporidian infecting field-caught mosquitoes that inhibits the… Read more »
The holy grail of malaria research must be the development of an extremely effective vaccine against Plasmodium falciparum, the… Read more »
A recent study of the P. falciparum chloroquine-resistance transporter points to mechanisms underlying resistance to chloroquine… Read more »
The very recent decline in malaria cases caused by Plasmodium falciparum in India is good news but disease burden close to half a… Read more »
It is unclear whether or not subpatent malaria should be targeted for control of the disease. A new study further unravels the… Read more »
Recently published work suggests a toxin from the bacterium, Escherichia coli, could be a therapeutic tool for treatment of… Read more »
BugBitten: A blog for the